Skip to main content
. 2014 May 27;2(2):397–421. doi: 10.3390/vaccines2020397

Figure 6.

Figure 6

The case when the mutation rate of Mutant 2 is high (ϵ2 = 2.7 × 101). Here, Mutant 1 has 10-fold resistance to the antibodies, Mutant 2 has 100-fold resistance to the antibodies and m = 10, recreating the conditions of Figure 3B, Figure 4B and Figure 5B (i.e., the cases of 10-fold magnification), except for the high mutation rate of Mutant 2. (A) Unlike Figure 3B, Mutant 2 escapes; (B) unlike Figure 4B, Mutant 1 persists; conversely, Mutant 2 is eradicated, despite its extremely high mutation rate; (C) the persistence of Mutant 1, similar to Figure 5B.